-
1
-
-
0025954489
-
Epidemiology of colonic symptoms and the irritable bowel syndrome
-
Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III: Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991, 101:927-934.
-
(1991)
Gastroenterology
, vol.101
, pp. 927-934
-
-
Talley, N.J.1
Zinsmeister, A.R.2
Van Dyke, C.3
Melton III, L.J.4
-
2
-
-
0036094268
-
Diagnosis of irritable bowel syndrome
-
Olden KW: Diagnosis of irritable bowel syndrome. Gastroenterology 2002, 122:1701-1714.
-
(2002)
Gastroenterology
, vol.122
, pp. 1701-1714
-
-
Olden, K.W.1
-
3
-
-
33846423499
-
Role of infection in irritable bowel syndrome
-
Spiller RC: Role of infection in irritable bowel syndrome. J Gastroenterol 2007, 42(Suppl 17):41-47.
-
(2007)
J Gastroenterol
, vol.42
, Issue.SUPPL. 17
, pp. 41-47
-
-
Spiller, R.C.1
-
4
-
-
33745659814
-
Systematic review: The efficacy of treatments for irritable bowel syndrome - a European perspective
-
Tack J, Fried M, Houghton LA, et al.: Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective. Aliment Pharmacol Ther 2006, 24:183-205.
-
(2006)
Aliment Pharmacol Ther
, vol.24
, pp. 183-205
-
-
Tack, J.1
Fried, M.2
Houghton, L.A.3
-
5
-
-
34147132358
-
Critical evaluation of probiotic activity of lactic acid bacteria and their effects
-
Heczko PB, Strus M, Kochan P: Critical evaluation of probiotic activity of lactic acid bacteria and their effects. J Physiol Pharmacol 2006, 57(Suppl 9):5-12.
-
(2006)
J Physiol Pharmacol
, vol.57
, Issue.SUPPL. 9
, pp. 5-12
-
-
Heczko, P.B.1
Strus, M.2
Kochan, P.3
-
6
-
-
33846452536
-
Is there a role for probiotics in irritable bowel syndrome?
-
Camilleri M: Is there a role for probiotics in irritable bowel syndrome? Dig Liver Dis 2006, 38(Suppl 2);S266-S269.
-
(2006)
Dig Liver Dis
, vol.38
, Issue.SUPPL. 2
-
-
Camilleri, M.1
-
7
-
-
33750360362
-
Bacterial overgrowth as a cause of irritable bowel syndrome
-
Riordan SM, Kim R: Bacterial overgrowth as a cause of irritable bowel syndrome. Curr Opin Gastroenterol 2006, 22:669-673.
-
(2006)
Curr Opin Gastroenterol
, vol.22
, pp. 669-673
-
-
Riordan, S.M.1
Kim, R.2
-
8
-
-
0035006468
-
Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats
-
Husebye E, Hellstrom PM, Sundler F, et al.: Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001, 280:G368-G380.
-
(2001)
Am J Physiol Gastrointest Liver Physiol
, vol.280
-
-
Husebye, E.1
Hellstrom, P.M.2
Sundler, F.3
-
10
-
-
0034048222
-
Bile salt hydrolase of Bifidobacterium longum-biochemical and genetic characterization
-
Tanaka H, Hashiba H, Kok J, Mierau I: Bile salt hydrolase of Bifidobacterium longum-biochemical and genetic characterization. Appl Environ Microbiol 2000, 66:2502-2512.
-
(2000)
Appl Environ Microbiol
, vol.66
, pp. 2502-2512
-
-
Tanaka, H.1
Hashiba, H.2
Kok, J.3
Mierau, I.4
-
11
-
-
0033251402
-
Screening of lactic acid bacteria for bile salt hydrolase activity
-
Tanaka H, Doesburg K, Iwasaki T, Mierau I: Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci 1999, 82:2530-2535.
-
(1999)
J Dairy Sci
, vol.82
, pp. 2530-2535
-
-
Tanaka, H.1
Doesburg, K.2
Iwasaki, T.3
Mierau, I.4
-
12
-
-
0042344991
-
Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patiens with Crohn's disease
-
Boudeau J, Glasser AL, Julien S, et al.: Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patiens with Crohn's disease. Aliment Pharmacol Ther 2003, 18:45-56.
-
(2003)
Aliment Pharmacol Ther
, vol.18
, pp. 45-56
-
-
Boudeau, J.1
Glasser, A.L.2
Julien, S.3
-
13
-
-
0344035326
-
Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game
-
Freitas M, Tavan E, Cayuela C, et al.: Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biol Cell 2003, 95:503-506.
-
(2003)
Biol Cell
, vol.95
, pp. 503-506
-
-
Freitas, M.1
Tavan, E.2
Cayuela, C.3
-
14
-
-
0032958362
-
Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression
-
Mack DR, Michail S, Wei S, et al.: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999, 276:G941-G950.
-
(1999)
Am J Physiol
, vol.276
-
-
Mack, D.R.1
Michail, S.2
Wei, S.3
-
15
-
-
0038237678
-
Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro
-
Mack DR, Ahrne S, Hyde L, et al.: Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003, 52:827-833.
-
(2003)
Gut
, vol.52
, pp. 827-833
-
-
Mack, D.R.1
Ahrne, S.2
Hyde, L.3
-
17
-
-
0034831139
-
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
-
Madsen K, Cornish A, Soper P, et al.: Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121:580-591.
-
(2001)
Gastroenterology
, vol.121
, pp. 580-591
-
-
Madsen, K.1
Cornish, A.2
Soper, P.3
-
18
-
-
4644249955
-
-
Wehkamp J, Harder J, Wehkamp K, et al.: NF-kappaB-and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 2004, 72:5750-S758.
-
Wehkamp J, Harder J, Wehkamp K, et al.: NF-kappaB-and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 2004, 72:5750-S758.
-
-
-
-
19
-
-
0033762339
-
Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity
-
Lievin V, Peiffer I, Hudault S, et al.: Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 2000, 47:646-652.
-
(2000)
Gut
, vol.47
, pp. 646-652
-
-
Lievin, V.1
Peiffer, I.2
Hudault, S.3
-
20
-
-
1642555518
-
Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50
-
Xiao H, Chen X, Chen M, et al.: Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50. Microbiology 2004, 150:103-108.
-
(2004)
Microbiology
, vol.150
, pp. 103-108
-
-
Xiao, H.1
Chen, X.2
Chen, M.3
-
21
-
-
17044456969
-
The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo
-
Bernet-Camard MF, Lievin V, Brassart D, et al.: The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 1997, 63:2747-2753.
-
(1997)
Appl Environ Microbiol
, vol.63
, pp. 2747-2753
-
-
Bernet-Camard, M.F.1
Lievin, V.2
Brassart, D.3
-
22
-
-
17044444528
-
Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB
-
Coconnier MH, Lievin V, Bernet-Camard MF, et al.: Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 1997, 41:1046-1052.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 1046-1052
-
-
Coconnier, M.H.1
Lievin, V.2
Bernet-Camard, M.F.3
-
23
-
-
15744374565
-
Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles
-
O'Mahony L, McCarthy J, Kelly P, et al.: Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541-551.
-
(2005)
Gastroenterology
, vol.128
, pp. 541-551
-
-
O'Mahony, L.1
McCarthy, J.2
Kelly, P.3
-
24
-
-
33947324517
-
Immune activation in patients with irritable bowel syndrome
-
Liebregts T, Adam B, Bredack C, et al.: Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132:913-920.
-
(2007)
Gastroenterology
, vol.132
, pp. 913-920
-
-
Liebregts, T.1
Adam, B.2
Bredack, C.3
-
25
-
-
14844349149
-
Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells
-
Di Giacinto C, Marinaro M, Sanchez M, et al.: Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 2005, 174:3237-3246.
-
(2005)
J Immunol
, vol.174
, pp. 3237-3246
-
-
Di Giacinto, C.1
Marinaro, M.2
Sanchez, M.3
-
26
-
-
2142810997
-
DNA from probiotic bacteria modulates murine and human epithelial and immune function
-
Jijon H, Backer J, Diaz H, et al.: DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004, 126:1358-73.
-
(2004)
Gastroenterology
, vol.126
, pp. 1358-1373
-
-
Jijon, H.1
Backer, J.2
Diaz, H.3
-
27
-
-
33646551486
-
Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius
-
O'Hara AM, O'Regan P, Fanning A, et al.: Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006, 118:202-15.
-
(2006)
Immunology
, vol.118
, pp. 202-215
-
-
O'Hara, A.M.1
O'Regan, P.2
Fanning, A.3
-
28
-
-
33750239826
-
Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells
-
Helwig U, Lammers KM, Rizzello F, et al.: Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol 2006, 12:5978-86.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 5978-5986
-
-
Helwig, U.1
Lammers, K.M.2
Rizzello, F.3
-
29
-
-
0020665293
-
Traitement des Colopathies Fonctionnelles - essai en double aveugle de l'ultra - leuvre
-
Maupas JL, Champemont P, Delforge M: Traitement des Colopathies Fonctionnelles - essai en double aveugle de l'ultra - leuvre. Medicine et Chirurgie Digestives 1983, 12:77-79.
-
(1983)
Medicine et Chirurgie Digestives
, vol.12
, pp. 77-79
-
-
Maupas, J.L.1
Champemont, P.2
Delforge, M.3
-
30
-
-
0029738351
-
Treatment of irritable bowel syndrome with Lacteol Fort: A randomized, double-blind, cross-over trial
-
Halpern GM, Prindiville T, Blankenburg M, et al.: Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 1996, 91:1579-1585.
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 1579-1585
-
-
Halpern, G.M.1
Prindiville, T.2
Blankenburg, M.3
-
31
-
-
0034059773
-
Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome
-
Nobaek S, Johansson ML, Molin G, et al.: Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000, 95:1231-1238.
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 1231-1238
-
-
Nobaek, S.1
Johansson, M.L.2
Molin, G.3
-
32
-
-
0034767063
-
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
-
Niedzielin K, Kordecki H, Birkenfeld B: A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001, 13:1143-1147.
-
(2001)
Eur J Gastroenterol Hepatol
, vol.13
, pp. 1143-1147
-
-
Niedzielin, K.1
Kordecki, H.2
Birkenfeld, B.3
-
33
-
-
33745569311
-
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
-
Whorwell PJ, Altringer L, Morel J, et al.: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006, 101:1581-1590.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 1581-1590
-
-
Whorwell, P.J.1
Altringer, L.2
Morel, J.3
-
34
-
-
0037392231
-
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
-
Kim HJ, Camilleri M, McKinzie S, et al.: A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003, 17:895-904.
-
(2003)
Aliment Pharmacol Ther
, vol.17
, pp. 895-904
-
-
Kim, H.J.1
Camilleri, M.2
McKinzie, S.3
-
35
-
-
25844477007
-
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating
-
Kim HJ, Vazquez Roque MI, Camilleri M, et al.: A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005, 17:687-696.
-
(2005)
Neurogastroenterol Motil
, vol.17
, pp. 687-696
-
-
Kim, H.J.1
Vazquez Roque, M.I.2
Camilleri, M.3
-
36
-
-
24344472329
-
A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention
-
Kajander K, Hatakka K, Poussa T, et al.: A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 2005, 22:387-394.
-
(2005)
Aliment Pharmacol Ther
, vol.22
, pp. 387-394
-
-
Kajander, K.1
Hatakka, K.2
Poussa, T.3
-
37
-
-
27744579575
-
Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: A methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study
-
Bittner AC, Croffut RM, Stranahan MC: Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study. Clin Ther 2005, 27:755-761.
-
(2005)
Clin Ther
, vol.27
, pp. 755-761
-
-
Bittner, A.C.1
Croffut, R.M.2
Stranahan, M.C.3
-
38
-
-
33749170157
-
The effects of probiotics on symptoms of irritable bowel syndrome
-
Kim YG, Moon JT, Lee KM, et al.: The effects of probiotics on symptoms of irritable bowel syndrome: Korean J Gastroenterol 2006, 47:413-419.
-
(2006)
Korean J Gastroenterol
, vol.47
, pp. 413-419
-
-
Kim, Y.G.1
Moon, J.T.2
Lee, K.M.3
-
39
-
-
0033921870
-
Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study
-
O'Sullivan MA, O'Morain CA: Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000, 32:294-301.
-
(2000)
Dig Liver Dis
, vol.32
, pp. 294-301
-
-
O'Sullivan, M.A.1
O'Morain, C.A.2
-
40
-
-
0036845692
-
Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome
-
Sen S, Mullan MM, Parker TJ, et al.: Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002, 47:2615-2620.
-
(2002)
Dig Dis Sci
, vol.47
, pp. 2615-2620
-
-
Sen, S.1
Mullan, M.M.2
Parker, T.J.3
-
41
-
-
28944452948
-
The efficacy of Lactobacillas reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind, placebo-controlled, randomized study
-
Niv E, Naftali T, Hallak R, Vaisman N: The efficacy of Lactobacillas reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind, placebo-controlled, randomized study. Clin Nutr 2005, 24:925-931.
-
(2005)
Clin Nutr
, vol.24
, pp. 925-931
-
-
Niv, E.1
Naftali, T.2
Hallak, R.3
Vaisman, N.4
-
42
-
-
23944459103
-
The use of Lactobacillus GG in irritable bowel syndrome in children: A double-blind randomized control trial
-
Bausserman M, Michail S: The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 2005, 147:197-201.
-
(2005)
J Pediatr
, vol.147
, pp. 197-201
-
-
Bausserman, M.1
Michail, S.2
-
43
-
-
13944255868
-
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR
-
Malinen E, Rinttila T, Kajander K, et al.: Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005, 100:373-382.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 373-382
-
-
Malinen, E.1
Rinttila, T.2
Kajander, K.3
-
44
-
-
33646570547
-
Measuring successful treatment of irritable bowel syndrome: Is "satisfactory relief" enough?
-
Schoenfeld P, Talley NJ: Measuring successful treatment of irritable bowel syndrome: is "satisfactory relief" enough? Am J Gastroenterol 2006, 101:1066-1068.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 1066-1068
-
-
Schoenfeld, P.1
Talley, N.J.2
-
45
-
-
0032485784
-
Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures
-
Tuomola EM, Salminen SJ: Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 1998, 41:45-51.
-
(1998)
Int J Food Microbiol
, vol.41
, pp. 45-51
-
-
Tuomola, E.M.1
Salminen, S.J.2
-
46
-
-
33846288886
-
Strain- and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaccous bacterial compounds
-
Tallon R, Arias S, Bressollier P, Urdaci MC: Strain- and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaccous bacterial compounds. J Appl Microbiol 2007, 102:442-451.
-
(2007)
J Appl Microbiol
, vol.102
, pp. 442-451
-
-
Tallon, R.1
Arias, S.2
Bressollier, P.3
Urdaci, M.C.4
-
47
-
-
0036130169
-
Adhesion of dairy propionibacteria to intestinal epithetial tissue in vitro and in vivo
-
Zarate G, Morata de Ambrosini VI, Chaia AP, Gonzalez SN: Adhesion of dairy propionibacteria to intestinal epithetial tissue in vitro and in vivo. J Food Prot 2002, 65:534-539.
-
(2002)
J Food Prot
, vol.65
, pp. 534-539
-
-
Zarate, G.1
Morata de Ambrosini, V.I.2
Chaia, A.P.3
Gonzalez, S.N.4
-
48
-
-
0036972368
-
Interaction of lactic acid bacteria with the gut immune system
-
Perdigon G, Maldonado Galdeano C, et al.: Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 2002, 56(Suppl 4):S21-S26.
-
(2002)
Eur J Clin Nutr
, vol.56
, Issue.SUPPL. 4
-
-
Perdigon, G.1
Maldonado Galdeano, C.2
|